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Molecular quantification of 
Plasmodium parasite density from 
the blood retained in used RDts
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Most malaria-endemic countries are heavily reliant upon rapid diagnostic tests (RDT) for malaria case 
identification and treatment. RDT previously used for malaria diagnosis can subsequently be used 
for molecular assays, including qualitative assessment of parasite species present or the carriage 
of resistance markers, because parasite DNA can be extracted from the blood inside the RDT which 
remains preserved on the internal components. However, the quantification of parasite density has 
not previously been possible from used RDT. In this study, blood samples were collected from school-
age children in Western Kenya, in the form of both dried blood spots on Whatman filter paper, and 
the blood spot that is dropped into rapid diagnostic tests during use. Having first validated a robotic 
DNA extraction method, the parasite density was determined from both types of sample by duplex 
qPCR, and across a range of densities. The methods showed good agreement. The preservation of 
both parasite and human DNA on the nitrocellulose membrane inside the RDT was stable even after 
more than one year’s storage. This presents a useful opportunity for researchers or clinicians wishing 
to gain greater information about the parasite populations that are being studied, without significant 
investment of resources.
Sensitive and specific diagnosis of malaria becomes increasingly important as malaria prevalence in many regions 
continues to decline1, due to scaling-up of control interventions and improved anti-malarial chemotherapy2. In 
many regions, a decline in malaria prevalence results in a transition from Plasmodium infections that are pre-
dominantly characterised by high parasite density, to those of low parasite density3. Although the latter are harder 
to detect, malaria elimination programmes seek to identify all infected individuals, regardless of symptoms or 
parasite density, to administer anti-malarial drugs and therefore to prevent onwards transmission. The use of 
diagnostic tools for malaria is dependent upon the setting, but as the burden of malaria falls disproportionately 
upon some of the world’s poorest populations4, diagnosis is often constrained by resources. Current recommen-
dations from the World Health Organisation are that malaria is diagnosed by microscopy and/or rapid diagnos-
tic test (RDT)1. While microscopy can be a highly sensitive method when conducted proficiently using a thick 
blood film (for example, by thick film, 10 parasites per μL blood [p/μL] were detected by a lead microscopist in a 
reference laboratory in the UK)5, allowing the operator to screen many blood cells, the sensitivity and precision 
of this method is dependent upon the microscopist and their level or access to training6. Although an accepted 
problem, there is evidence that in some settings standards of malaria diagnostic microscopy may be declining7–9. 
Rapid diagnostic tests are composed of a plastic or cardboard cassette containing a nitrocellulose strip, on which 
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a band of monoclonal antibodies are visualised if they bind certain Plasmodium proteins, set within absorptive 
padding. They are widely available, cheap, and easy to use. However, RDT are less sensitive than microscopy (usu-
ally with a limit of detection [LOD] of approximately 100 p/μL)10–12 and they cannot give a quantitative estimate 
of the patient’s parasite burden. Further, they cannot be used to confirm parasite clearance following treatment, 
as circulating Plasmodium proteins (e.g. histidine-rich protein-2 (HRP-2)) from recently deceased parasites can 
continue to indicate positivity10,13. Due to these drawbacks, it is recommended by the World Health Organisation 
(WHO) that microscopy and RDT results are routinely compared in the field14.
In recent years, molecular techniques for detecting parasite DNA have been applied to the blood samples 
that are collected during the process of routine malaria diagnosis. The first studies of this kind applied poly-
merase chain reaction (PCR) to Giemsa-stained blood smears used previously for diagnostic microscopy15,16. 
Since then, several studies have recognised the dried blood within used RDT as a valuable source of parasite 
DNA, and successfully applied molecular analysis to this template. The advantages of this are multiple: RDT are 
widely deployed across all malaria endemic settings, the volume of blood required is generally small (e.g. 5 µL), 
minimising discomfort and inconvenience to the patient, there are minimal storage requirements, and DNA 
amplification from the blood inside used RDT (RDTDNA) has repeatedly been shown to be successful up to one 
year post-collection17–20. Further, there is very little possibility of cross-contamination since blood is contained 
within the RDT cassette, and retrospective clinical and research studies can be undertaken where whole blood or 
dried blood spot samples for DNA extraction were not specifically collected. While initial studies of PCR from 
RDTDNA focussed on proof of principle and quality assessment of the PCR result18,21, it is now acknowledged 
that extraction and amplification of parasite DNA from RDTDNA can allow more in-depth molecular analysis, 
including parasite genotyping to identify emerging resistance or important polymorphisms including HRP-2 
deletions22, better monitoring of the progress of malaria control strategies and studies of parasite genetic diver-
sity18,20. The identification of different infecting Plasmodium species, and indeed mixed-species infections, has 
also been demonstrated21,23. Further, the use of such methods under different epidemiological and environmental 
settings has now been established, with an expanding evidence base that includes studies in French Guiana17, 
Tanzania18, Zanzibar19, Mali20 and the Comores23. Methods of DNA extraction from RDTDNA have been opti-
mised in terms of the extraction procedures themselves17,19, and importantly have also identified the optimal 
internal RDT component for targeted DNA extraction21, whilst accounting for possible variability according to 
the specific brand of RDT. However, to our knowledge, the quantification of patient parasite density based on 
RDTDNA has not previously been demonstrated.
The objective of this study was therefore to determine Plasmodium parasite burden in patients by duplex 
quantitative PCR (qPCR) based on RDTDNA. We validated this parasite quantification through comparison to that 
calculated using a simultaneously sampled dried blood spot on Whatman filter paper (DBSDNA). External valida-
tion is particularly critical in the context of RDTDNA because the nitrocellulose membrane that has been shown to 
best harbour good quality parasite DNA21 is nonetheless not designed to this end. In addition, as it is recognised 
that the advantages of RDTDNA include minimal long-term storage requirements, parasite quantification data after 
various storage times are needed to validate these conditions.
Results
Validation of robotic DNA extraction. We validated the quality of P. falciparum DNA derived from 
artificial dried blood spots (DBS) made with Dd2 and 3D7 cultures, by using a robotic extraction system 
(QIAsymphony, QIAGEN, Germany) with two different reagent and column kits from the Manufacturer (desig-
nated “Investigator” and “Blood”), in parallel with a manual (Chelex)24,25 extraction system. We then genotyped 
the extracted DNA using the commonly used pfcrt qPCR assay26. Both the manual and robotic extractions gave 
comparable results (Fig. 1), although the latter was slightly more efficient, exhibiting a lower average cycle thresh-
old (CT) value compared to the former (manual 30.16 ± 5.86; automatic “Investigator” 29.37 ± 5.95; automatic 
“Blood”, 29.56 ± 5.96 [mean CT ± standard deviation]). Both extraction methods detected the two pfcrt haplo-
types (CVMNK and CVIET in 3D7 and Dd2 parasites respectively) with a sensitivity as low as five parasites per 
microliter. The coefficient of variation (CV) at the lowest parasitaemia was 5.10% and 5.20% for “Blood” and 
“Investigator” kits respectively using the CVMNK probe and 5.10% and 5.12% respectively for the kits using 
the CVIET probe. We observed no difference in mean CT value between QIAGEN “Blood” kit and QIAGEN 
“Investigator” kit at the lowest parasitaemia (the latter is recommended for DNA extraction from DBS) (P = 0.51, 
paired t-test, SED = 2.4, DF = 5; Table 1), when used in the robotic system.
Correlation in parasite densities obtained in qPCR using two DNA templates. All blood samples 
used in this study were RDT and filter paper finger prick samples collected in parallel from participants in a 
malaria odour study (described elsewhere, Supplementary Fig. S1)27. Plasmodium parasite density, quantified by 
duplex qPCR, was correlated across the 141 RDTDNA and DBSDNA paired samples (r = 0.78, P < 0.001, F = 208.77), 
with no difference between the parasite densities obtained by either method (Wilcoxon Matched-Pairs test 
z = 0.475, P = 0.635, N = 141, Figs 2 and 3A). When only including pairs in which both the RDT and DBS sam-
ple was positive for parasite DNA (and both repeats of each sample), a good correlation remained (r = 0.53, 
P < 0.001, F = 15.41, n = 41, Fig. 3B) and no difference was observed between the values obtained from either 
method (Wilcoxon Matched-Pairs test z = −0.279, P = 0.781, n = 41). Although paired samples were only mar-
ginally different, there was a trend for the DBSDNA sample to give higher parasite densities across most of the range 
of parasite densities (deviation from 1:1 correlation, Fig. 3A).
Performance of templates for DNA storage and amplification. Parasite density was estimated by 
qPCR from one RDTDNA sample to be 0.05 p/μL, with both repeats positive, suggesting a low limit of detection for 
this assay based on a RDTDNA template. Further, given the correlation in parasite density obtained here between 
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these two templates, and accepted ability of Whatman filter paper to preserve DNA, we deduce that storage of 
RDTDNA for over a year (14 months: sample collection 15/05/2014–10/07/2014, first DNA extraction 28/09/2015) 
did not lead to DNA degradation.
We used the recovery of human DNA (HumTuBB) to perform an exploratory analysis, comparing the amount 
of DNA recovered from the two template types. By taking advantage of the within-PCR-plate normalisation 
of HumTuBB amplification CT value to the international standard (i.e. delta CT)28, we observed a difference 
between RDT and DBS sample pairs (P < 0.001, N = 141, Sign test), despite total surface area of the two template 
types available for extraction being approximately equal. A non-zero, positive median ratio of RDT:DBS delta CT 
values (median = 2.64, IQR: 0.83–7.67) indicated that RDT delta CT was more often a higher value, indicating a 
lower recovery of detectable human DNA.
Immunochromatographic test outcome vs. qPCR parasite quantification on two templates. 
Approximately one third of all samples with a positive RDT test result were found to be negative by qPCR 
(RDTDNA or DBSDNA), although there was not clear agreement on which samples were truly negative between the 
two PCR templates (Supplementary Table S1). Further, several samples yielded a negative RDT test result, were 
qPCR RDTDNA positive or ‘inconclusive’, but qPCR DBSDNA negative, indicating probable false positivity by qPCR 
RDTDNA (Supplementary Table S1). Samples were collected from participants over three timepoints, at zero, seven 
and 21 days (Supplementary Fig. S1). Rapid diagnostic test positivity and qPCR negativity was disproportionately 
observed in timepoint two, at seven days (RDT result positive, qPCR result ‘inconclusive’ or negative: timepoint 1, 
qPCR RDTDNA 32.3%, qPCR DBSDNA 25.8%; timepoint 2, qPCR RDTDNA 66.7%, qPCR DBSDNA 73.3%; timepoint 
3, qPCR RDTDNA 29.2%, qPCR DBSDNA 33.3%).
Discussion
Duplex qPCR was successfully used to quantify parasite density in paired samples, comprising used RDTs and 
dried blood spots on Whatman filter paper. Despite weak evidence of higher values derived from qPCR DBSDNA, 
no statistical difference in estimated parasite density was found between the paired samples. For this analysis, we 
successfully validated a robotic extraction system for extracting DNA derived from dried blood spots. Lower CT 
Figure 1. Comparison of the performance of the manual (chelex, solid lines) and automatic (QIAsymphony, 
dashed lines) systems for DNA extraction prior to qPCR genotyping of the pfcrt gene. (A) Extraction from the 
P. falciparum 3D7 pfcrt haplotype CVMNK, and (B) extraction from the P. falciparum Dd2 pfcrt haplotype 
CVIET. NTC is no template control.
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Format Method* DNA dilution (p/μL)
3D7 CVMNK Dd2 CVIET
Mean Ct Ct STD Ct CI Mean Ct Ct STD Ct CI
Manual Chelex
1:1 (50000) 22.86 0.34 22.58–23.14 23.10 0.28 22.87–23.33
1:10 (5000) 25.91 0.74 25.31–26.51 25.61 0.56 25.15–26.07
1:100 (500) 27.92 0.36 27.63–28.21 27.45 0.34 27.17–27.73
1:1000 (50) 30.28 0.26 30.07–30.49 30.35 0.31 30.10–30.60
1:5000 (5) 35.94 0.47 35.56–36.32 36.21 0.53 35.78–36.64
1:10000 (1) 38.02 2.00 36.39–39.65 38.60 1.89 37.06–40.14
Automatic
Investigator
1:1 (50000) 21.8 0.30 21.56–22.04 22.72 0.49 22.32–23.12
1:10 (5000) 25.28 0.02 25.26–25.30 26.79 0.10 26.71–26.87
1:100 (500) 26.3 0.42 25.96–26.64 29.76 0.47 29.38–30.14
1:1000 (50) 30.61 1.14 29.68–31.54 29.60 0.37 29.30–29.90
1:5000 (5) 35.51 0.52 35.09–35.93 35.21 0.26 35.00–35.42
1:10000 (1) 36.72 1.91 35.16–38.28 36.80 1.86 35.28–38.32
Blood
1:1 (50000) 21.2 0.11 21.11–21.29 22.50 0.12 22.40–22.60
1:10 (5000) 25.28 0.17 25.14–25.42 26.51 0.24 26.31–26.71
1:100 (500) 27.99 0.09 27.92–28.06 29.60 0.46 29.22–29.98
1:1000 (50) 30.75 0.09 30.68–30.82 29.62 0.23 29.43–29.81
1:5000 (5) 35.39 0.78 34.75–36.03 35.31 0.81 34.65–35.97
1:10000 (1) 36.72 1.91 35.16–38.28 36.40 1.86 34.88–37.92
Table 1. Cycle threshold (CT) values obtained during qPCR of the pfcrt haplotypes CVMNK and CVIET in 
the 3D7 and Dd2 P. falciparum strains, respectively), following manual (chelex) or robotic (QIAsymphony) 
extraction. *The robotic system was tested with two kits, “Blood” and “Investigator”, that latter being specifically 
recommended for use in DBS extraction.
Figure 2. Parasite density measured by duplex qPCR, from a DNA template based on RDTDNA (blue bars) or 
DBSDNA (pink bars) (n = 108). Ordered by (A) RDTDNA value, (B) DBSDNA value (samples for which both results 
were zero are not shown, n = 33). Multiple values at 1.43 (0.93 + 0.5) p/μL represent ‘inconclusive’ samples 
(those that gave one positive and one negative repeat, which were universally allocated the median positive 
value for such samples, 0.93).
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values, indicating more rapid DNA amplification, were observed in qPCR assays based on robotically extracted 
template. This can be interpreted as improved extraction performance by the robotic system relative to the man-
ual system and may reflect the superiority in DNA quality generated by the robotic system. Similarly, lower CT 
values for the human gene were observed in qPCR assays based on DBS template relative to used RDT template 
in the paired field samples. This, and the skew towards higher parasitaemia values derived from qPCR DBSDNA, 
may be indicative of superior DNA quality derived from the Whatman filter paper dried blood spots relative to 
the used RDT.
As in previous studies that compared RDT results with qPCR amplification on the same sample, a propor-
tion (approximately one third) were found to be negative by qPCR while the RDT result was positive18,20,21,23. 
Circulating parasite antigen following anti-malarial chemotherapy would lead to this, because of continued anti-
gen detection by RDT. Indeed, we observed this disproportionately in the second sampling timepoint, where 
individuals were likely to have received anti-malarial chemotherapy. As the third timepoint was 21 days after the 
first timepoint and 14 days after the second, the drug effect on parasite density is less likely to be observed.
A high proportion of qPCR ‘inconclusive’ samples (one positive and one negative repeat) in the RDT negative 
samples was probably due to the prevalence of low-density infections often found in this endemic setting29,30. 
For such samples these discrepancies are more common. As the qPCR limit of detection, estimated from duplex 
qPCR assays to be approximately 0.05 parasites/μL, is considerably lower than that of a standard RDT (100–200 
p/μL)10, these samples most likely represent infections in which the parasite density fluctuates around the qPCR 
limit of detection. At such densities, stochastic effects can dictate whether parasite DNA is detected in the sample, 
in terms of the random likelihood of parasites in that particular blood aliquot, the randomness in the location of 
the parasites on the blood template, and the likelihood of that specific area of template being tested. Also contrib-
uting to the mismatch between RDT and qPCR results is the presence of P. falciparum hrp2 and hrp3 gene dele-
tions, known to affect the functionality of HRP-2-based RDT, and reported elsewhere from this study cohort22. Of 
these RDT negative qPCR positive samples, there was some disagreement between RDTDNA and DBSDNA template 
qPCR results. Again, this is most simply explained by the relatively high prevalence of low-density infections 
in this cohort, where parasite numbers fluctuate around the point of qPCR detection and stochasticity exists in 
sampling.
By using a duplex qPCR that normalises parasite DNA quantification relative to the quantity of a human gene 
(HumTuBB), our assay circumvents two possible problems in the use of RDTDNA as a quantitative DNA template: 
that the blood spot in an RDT is an imprecise volume, and that the nitrocellulose membrane was not designed to 
bind and store DNA and (as is suggested by our data) may do so with less efficiency than other substrates. Here, 
the amplification of HumTuBB constitutes an internal control, although poor amplification of HumTuBB should 
be identified and interpreted with caution, as this could lead to artificially raised estimates of Plasmodium para-
site density. We used a pan-genus qPCR test with a target sequence (pgmet tRNA gene) that is 100% identical in 
nucleotide sequence in all human-infecting Plasmodium species28. Our approach would be equally effective with 
a duplexed qPCR test with a species-specific target for Plasmodium falciparum, as this is the species represented 
in the International Standard (INT)31.
In finding that the stored blood deposit within used rapid diagnostic tests presents opportunities for future 
molecular analysis of the Plasmodium parasite population, we support the findings of other studies17–20,23,32. We 
further build on this finding by demonstrating that Plasmodium parasite densities can be estimated by qPCR from 
RDTDNA templates, with similar results as obtained from standard Whatman filter paper dried blood templates. 
This finding is of interest across a range of clinical and research settings, where in-depth retrospective molecu-
lar analysis of parasite populations can be undertaken following appropriate, minimal requirement, storage of 
RDTDNA. This study provides further evidence that the long-term storage (up to 14 months at −20 °C) of such 
RDTDNA has no effect on the outcome of retrospective molecular assays, as previously shown17–20. This is in keep-
ing with studies that suggest storage of DBS blood samples at −20 °C averts loss of assay sensitivity over time33, 
Figure 3. Parasite density measured by duplex qPCR, based on RDTDNA or DBSDNA. There was a good 
correlation between parasite density in these paired samples across the whole dataset (A) (r = 0.78, P < 0.001, 
F = 208.77, N = 141), and when considering only paired samples that were both positive (B) (r = 0.53, P < 0.001, 
F = 15.41, n = 41). Both correlations (dashed lines) are however different from a 1:1 relationship ((A) P < 0.001, 
t-test; (B) P = 0.026, t-test. Data points of value 1.03 in (A) are missing from (B) as samples with one positive 
and one negative PCR repeat are omitted (median parasitaemia = 1.03 [0.93 + 0.1], see methods ‘Parasite 
quantification’).
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and that this is not affected by a limited number of freeze-thaw cycles, as experienced by our samples during 
shipment. Further, other studies have successfully amplified parasite DNA from used rapid diagnostic tests that 
had been stored at ambient temperature for one18,21, three18 or 14 months20. It would be interesting to compare 
parasite quantification from used RDT among different RDT cassettes/brands. Parasite detection from used RDT 
from 12 RDT brands was previously reported, and variable Ct values were demonstrated21. Therefore, the corre-
lation between parasites densities obtained from DBSDNA and RDTDNA as described in the current paper may not 
be of similar strength to that obtained when using alternative RDT types.
In this study, rapid diagnostic tests previously used for malaria diagnosis in a cohort of 141 five- to 12-year-old 
children in Western Kenya were shown to provide a DNA template for Plasmodium parasite quantification 
of equal functionality to Whatman filter paper. This study further bolsters the literature indicating that rapid 
diagnostic tests, with adequate storage, can reliably be used for retrospective quantitative molecular studies of 
Plasmodium parasite population dynamics some months to years after original use.
Methods
ethics. Five- to 12-year-old, male and female school children were recruited to a ‘malaria odour’ study27 after 
informed consent was obtained from their parent or legal guardian. The study protocol (NON SSC 389) was 
approved by the Scientific and Ethical Review Committee of the Kenya Medical Research Institute (KEMRI) 
(KEMRI/RES/7/3/1). Subsequent analyses of the blood samples were conducted at the London School of Hygiene 
& Tropical Medicine (LSHTM) under the ethics reference 8510. All research was performed in accordance with 
relevant guidelines and regulations.
study site and population. Participants were recruited at four schools less than 10 km from the Thomas 
Odhiambo Campus of the International Centre of Insect Physiology and Ecology (ICIPE) in Western Kenya 
(0°25′48.1″S, 34°12′24.5″E), in Suba District, Homa Bay County. In this area, community livelihoods depend 
upon fishing, small-scale trading or subsistence farming, and the dominant ethnic group is Luo. Malaria is 
endemic and transmission peaks late in the rainy season (March to August). Parasite prevalence on the nearby 
Rusinga island, on Lake Victoria, at this time was estimated to be 30% across the whole population34.
Study design and sampling procedures. To inform sampling in the malaria odour study, partici-
pants were tested in the field for their Plasmodium parasite status using point-of-care methods (thick and thin 
blood film microscopy, and RDT [One Step malaria HRPII and pLDH antigen rapid test, SD BIOLINE, Cat no 
05FK60]). Individuals who were odour-sampled were followed up at two further time-points, approximately 
seven (R2) and 21 (R3) days later, as described previously27. Repeat sampling was intrinsic to the odour study 
but arbitrary to this study27 of parasite quantification methods. At each time-point, Plasmodium diagnosis was 
repeated, and positive individuals were treated with weight-dosed artemether-lumefantrine (AL) according to 
manufacturer’s instructions. Throughout the entire sampling period (January–July 2014), whole blood was stored 
for 18S and QT-NASBA molecular assays (reported elsewhere)27, and RDTDNA cassettes were stored for later 
analysis by bench-top air-drying for 24 hours, followed by storage in bundles in sealed plastic bags containing the 
desiccant silica gel (silicon dioxide). Between May and July, dried blood spots of approximately 5 mm were addi-
tionally collected onto Whatman No. 3 filter paper (DBSDNA). The latter samples provided a suitable comparator 
for RDTDNA as a qPCR DNA template. After air-drying, filter paper samples (RDTDNA and DBSDNA) were stored 
at −18 °C, other than when in transit from Kenya to London.
Robotic extraction validation. To validate the extraction of DNA using a robotic system, we used 
culture-adapted 3D7 and Dd2 strains of Plasmodium falciparum parasites. Strains were serially diluted in blood 
(five-fold, starting at 1% parasitaemia) to determine the sensitivity and limit of detection of DNA extraction using 
both a manual (Chelex) and robotic extraction system (QIAsymphony QIAGEN, Germany), across a range of 
parasite densities.
Robotic DNA extraction was performed according to the manufacturer’s instructions in a deep well plate 
using a robotic extraction system (QIAsymphony QIAGEN, Germany), using either of two kits: “Investigator” 
kit (recommended for extraction of DNA from filter paper) and “Blood” kit (recommended for extraction from 
whole blood). Details of the procedure can be found elsewhere22. Manual DNA extraction for comparison was 
performed using the Chelex method24.
Sample processing and extraction. Used RDT cassettes were opened laterally and the nitrocellulose strip 
was removed from inside. A central section of the nitrocellulose strip was cut out using a sterile scalpel blade and 
then into 1–3 small pieces of approximately 2 mm length21. All RDTDNA nitrocellulose pieces, per sample, were 
extracted together. A three mm diameter circle was punched from each DBSDNA using a sterile hole punch, giv-
ing a total surface area for extraction of approximately 7.07 mm2. Both template types were extracted using the 
robotic extraction system, with the QIAsymphony DSP DNA mini kit (QIAGEN, Germany) and according to the 
manufacturer’s instructions. In brief, buffer ATL (180 μL) and proteinase K (20 μL) were added to each well and 
mixed by thermomixer at 900 rpm at 560C for 15 minutes. The deep-well plate was then placed directly into the 
sample compartment of the QIAsymphony for DNA extraction.
Parasite quantification. Parasite density was measured by a duplex qPCR as described previously28 and 
used previously in western Kenya35. This assay is designed to enable parasite quantification when the volume of 
blood in the sample is unknown, by normalisation against human signal. Briefly, fragments of the Plasmodium 
methionine tRNA gene and the human beta tubulin exon 4 gene (HumTuBB) were amplified simultaneously 
and detected by hydrolysis probes detected on separate fluorescent channels, allowing internal normalisation 
for DNA extraction efficiency. DNA extract from either RDTDNA or DBSDNA template (5 μL) was added to the 
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qPCR reaction, with no-template and positive control reactions set up per PCR plate in duplicate, the latter 
being the INT for P. falciparum DNA31. Amplification assays were performed using probe-based quantitative 
PCR on RG3000 and RG6000 thermo-cyclers, with cycle conditions as described previously28. Positive samples 
were defined as those that crossed a pre-determined threshold of 0.025, and the cycle threshold (CT) value was 
taken to be the cycle number at which the amplification curve crossed this threshold. Ct values for the parasite 
probe fluorescence of each sample, including INT, were normalised to the HumTuBB gene probe fluorescence and 
parasite density calculated as described previously28. Specifically, the WHO INT DNA standard for P. falciparum 
comprises lyophilised blood from a hyper-parasitaemic patient who underwent exchange transfusion with an 
estimated parasite density pre-freezing of 4.9 × 105 parasites per μL whole blood31. When reconstituted with 
500 μL of water as the final reagent, each vial contains 500 million International Units (IU) of P. falciparum DNA. 
This represents 250 million parasite genome equivalents (i.e. 500 μL of human blood carrying 4.9 × 105 parasites 
per μL), and so 1IU approximates 0.5 parasite genome equivalents, using our qPCR method.
All samples were amplified in duplicate and the average parasite density was obtained per sample. If the two 
repeats were positive and negative, an overall parasite density of 0.93 p/μL was assigned (median parasite den-
sity of all the positive samples in this category, across the entire malaria odour study, n = 71), and these samples 
termed ‘inconclusive’.
statistical analysis. We compared limit of detection of the pfcrt qPCR assay on DNA extracted using two 
Qiagen kits (investigator and blood). The difference in mean CT value over the different dilutions was com-
pared using a paired t-test (n = 6, analyses performed in Stata [v. 15, StatCorp]). We analysed qPCR data using 
Rotor-Gene Q software (version 2.3.1, Qiagen), before comparing parasite densities obtained using RDTDNA or 
DBSDNA template by application of the Wilcoxon Matched Pairs Test. Quantities of DNA for RDT and DBS sample 
pairs were compared using the Sign test. Pearson correlations (r) between parasite densities from the two tem-
plates were tested using the F-test having first transformed the data using a natural logarithm with an adjustment 
(0.1) to allow for zero observations (analyses performed in Stata [v. 15, StatCorp]).
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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